Lv1
8 积分 2022-07-07 加入
The allosteric IDH1 inhibitor ivosidenib overcomes chemoresistance in intrahepatic cholangiocarcinoma models expressing wild-type IDH1
1个月前
已完结
The allosteric IDH1 inhibitor ivosidenib overcomes chemoresistance in intrahepatic cholangiocarcinoma models expressing wild-type IDH1
2个月前
已完结
Immunotherapy for hepatocellular carcinoma
2个月前
已完结
Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
2个月前
已完结
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma
2个月前
已完结
Changing epidemiology of hepatocellular carcinoma in Asia
2个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2个月前
已完结
Global Epidemiology and Genetics of Hepatocellular Carcinoma
2个月前
已完结
Liver cancer in 2021: Global Burden of Disease study
2个月前
已完结
Nuclear translocation of YAP drives BMI‐associated hepatocarcinogenesis in hepatitis B virus infection
5个月前
已完结
皖公网安备34019202002308
